Celltrion Pharm, Inc. (KOSDAQ:068760)
South Korea · Delayed Price · Currency is KRW 71,800
-1,100 (-1.51%)
Feb 27, 2026, 3:30 PM KST
Celltrion Pharm Market Cap
Celltrion Pharm has a market cap or net worth of 3.12 trillion as of February 27, 2026. Its market cap has increased by 41.33% in one year.
Market Cap
3.12T
Enterprise Value
n/a
Revenue
274.73B
Ranking
n/a
PE Ratio
123.08
Stock Price
71,800.00
Market Cap Chart
Since February 3, 2006, Celltrion Pharm's market cap has increased from 66.37B to 3.12T, an increase of 4,605.35%. That is a compound annual growth rate of 21.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 3.12T | 21.36% |
| Dec 30, 2025 | 2.57T | 4.33% |
| Dec 30, 2024 | 2.47T | -35.41% |
| Dec 28, 2023 | 3.82T | 44.48% |
| Dec 29, 2022 | 2.64T | -43.45% |
| Dec 30, 2021 | 4.67T | -46.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 8.24T |
| Hanmi Pharm. | 7.53T |
| Hanall Biopharma | 3.10T |
| Daewoong Pharmaceutical | 2.08T |
| GC Biopharma | 1.90T |
| Chong Kun Dang Pharmaceutical | 1.22T |
| Ildong Pharmaceutical | 1.16T |
| Daewoong | 1.12T |